CAPN1 and Alzheimer disease: Correlation of calpain-1 with calpain-cleaved α-spectrin and p25 amounts provided further confirmation of aberrant calpain-1 proteolytic activity in AD brain (p < 0.05 for both; Fig. 6b, c).